BIOAVAILABILITY OF SUSTAINED-RELEASE AND NON SUSTAINED-RELEASE ISOSORBIDE-5-MONONITRATE

被引：0
|
作者：
MUCK, B
BONN, R
RIETBROCK, N
机构：
来源：
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1989年 / 39-2卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1274 / 1276
页数：3
相关论文
共 50 条
  • [1] PHARMACOKINETIC PROFILE AND BIOAVAILABILITY OF A NEW GALENIC FORMULATION OF ISOSORBIDE-5-MONONITRATE SUSTAINED-RELEASE FORMULATION
    SKUTTA, T
    BOTTCHER, B
    BRANDT, L
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-1 (04): : 507 - 511
  • [2] Counterregulatory responses: Sustained-release isosorbide-5-mononitrate versus transdermal nitroglycerin
    Parker, JD
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (05) : 631 - 638
  • [3] INTERVAL TREATMENT OF CORONARY-ARTERY DISEASE WITH SUSTAINED-RELEASE ISOSORBIDE-5-MONONITRATE
    JANSEN, W
    PRENZE, R
    KUMPER, H
    TAUCHERT, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (21): : J16 - J22
  • [4] CLINICAL CHRONOPHARMACOLOGY OF ORAL SUSTAINED-RELEASE ISOSORBIDE-5-MONONITRATE IN HEALTHY-SUBJECTS
    LEMMER, B
    SCHEIDEL, B
    BLUME, H
    BECKER, HJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (01) : 71 - 75
  • [5] Antiischemic efficacy of sustained-release isosorbide-5-mononitrate - Echocardiography during physical and mental stress
    Keck, M
    Tretter, R
    Sauerbrey-Wullkopf, N
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 2001, 90 (10): : 766 - 773
  • [6] ANTIANGINAL EFFICACY AND DURATION OF ACTION OF 40-MG ISOSORBIDE-5-MONONITRATE IN SUSTAINED-RELEASE FORM
    REALE, A
    ROMEO, F
    GIOFFRE, PA
    GRECO, C
    MASCHIETTI, A
    UBERBACHER, HJ
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (06): : 912 - 919
  • [7] Sustained-Release Isosorbide-5-Mononitrate Improves Exercise Capacity 30 Minutes after Oral Application
    J. Guzik
    M. Kanopka
    J. Maciejewicz
    A. Maziarz
    J. Stepien
    [J]. Clinical Drug Investigation, 1997, 14 : 117 - 124
  • [8] Sustained-release isosorbide-5-mononitrate improves exercise capacity 30 minutes after oral application
    Guzik, J
    Kanopka, M
    Maciejewicz, J
    Maziarz, A
    Stepien, J
    [J]. CLINICAL DRUG INVESTIGATION, 1997, 14 (02) : 117 - 124
  • [9] BIOAVAILABILITY OF ISOSORBIDE DINITRATE AND ITS 2 MONONITRATE METABOLITES FROM SUSTAINED-RELEASE FORMULATIONS
    CHASSEAUD, LF
    DOYLE, E
    TAYLOR, T
    DARRAGH, A
    LAMBE, RF
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1983, 21 (10) : 514 - 518
  • [10] Clinical evaluation of efficacy of a sustained-release preparation of isosorbide-5-mononitrate in patients with chronic ischemic heart disease
    Pushin, YM
    Nikolaeva, EP
    Churina, SK
    Churin, VD
    Nedoshivin, AO
    [J]. KARDIOLOGIYA, 1999, 39 (02) : 45 - 48
12345